Abstract
In this issue of Cancer Cell, Singh and colleagues report a role for MUC1-induced HIF expression in rewiring ribose synthesis, which drives pyridimine production as a possible resistance mechanism to gemcitabine, adding to complexity and multiple paths to resistance. In this issue of Cancer Cell, Singh and colleagues report a role for MUC1-induced HIF expression in rewiring ribose synthesis, which drives pyridimine production as a possible resistance mechanism to gemcitabine, adding to complexity and multiple paths to resistance.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3-5 |
| Number of pages | 3 |
| Journal | Cancer cell |
| Volume | 32 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jul 10 2017 |
| Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research
Fingerprint
Dive into the research topics of 'MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS